Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Nektar Therapeutics
DescriptionLong acting Interleukin-15 (IL-15) conjugated to polyethylene glycol (PEG) by a hydrolyzable linker
Molecular Target Interleukin-15 (IL-15)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today